Structure Therapeutics develops life-changing medicines for patients using advanced structure-based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical-stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions. Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location. POSITION SUMMARY The position supports statistical programming for Phase 3 studies and regulatory submissions, ensuring high-quality, compliant deliverables aligned with CDISC standards and global regulatory requirements (e.g., FDA, EMA). The role maintains oversight of work performed by CROs, including review and verification of outputs to ensure accuracy and compliance; contributes to data review and cleaning; and advances internal programming capabilities through development of macros, processes, and automation to improve efficiency and consistency. Operating with a high degree of independence, they partner cross-functionally to ensure high-quality, timely delivery of statistical programming outputs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior